BioRestorative Therapies, Inc.
BRTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $11,102 | $7,339 | $9,949 | $5,155 |
| - Cash | $548 | $884 | $1,714 | $21,027 |
| + Debt | $0 | $162 | $302 | $671 |
| Enterprise Value | $10,555 | $6,617 | $8,537 | -$15,201 |
| Revenue | $401 | $146 | $120 | $46 |
| % Growth | 175% | 21.7% | 160.4% | – |
| Gross Profit | $373 | $146 | $120 | $46 |
| % Margin | 93% | 100% | 100% | 100% |
| EBITDA | -$11,366 | -$14,972 | -$18,743 | -$26,219 |
| % Margin | -2,834.4% | -10,268.7% | -15,645.2% | -56,997.3% |
| Net Income | -$8,979 | -$10,418 | -$13,222 | -$44,303 |
| % Margin | -2,239.2% | -7,145.2% | -11,037% | -96,311.5% |
| EPS Diluted | -1.16 | -2.47 | -3.65 | -37.3 |
| % Growth | 53% | 32.3% | 90.2% | – |
| Operating Cash Flow | -$8,230 | -$6,430 | -$5,913 | -$3,330 |
| Capital Expenditures | -$106 | -$171 | -$440 | -$31 |
| Free Cash Flow | -$8,337 | -$6,601 | -$6,353 | -$3,361 |